| Emergency Medical Services | Lifetime | 45 | GB 5 | 99.42 |
| Nephrology | Lifetime | 68 | GB 2 | 99.50 |
| Surgery | Lifetime | 674 | GB 50 | 99.36 |
| Hepatology | Lifetime | 463 | GB 25 | 95.75 |
| Emergency Medicine | Lifetime | 920 | GB 82 | 88.32 |
| Internal Medicine | Lifetime | 482 | GB 36 | 86.43 |
| Nephrology | 2021-2025 | 56 | GB 6 | 98.36 |
| Surgery | 2021-2025 | 507 | GB 29 | 95.88 |
| Medical Physiology | 2021-2025 | 337 | GB 38 | 95.39 |
| Emergency Medical Services | 2021-2025 | 97 | GB 9 | 90.40 |
| Nutrition and Dietetics | 2021-2025 | 357 | GB 19 | 84.26 |
| Geriatrics and Gerontology | 2021-2025 | 157 | GB 20 | 82.20 |
| Pathology and Forensic Medicine | 2021-2025 | 555 | GB 31 | 67.17 |
| Central Venous Catheters and Hemodialysis | Lifetime | 40 | GB 1 | 99.52 |
| Dialysis and Renal Disease Management | Lifetime | 68 | GB 1 | 99.52 |
| Acute Kidney Injury Research | Lifetime | 45 | GB 2 | 99.31 |
| Muscle and Compartmental Disorders | Lifetime | 22 | GB 2 | 99.35 |
| Hemodynamic Monitoring and Therapy | Lifetime | 90 | GB 9 | 99.25 |
| Renal function and acid-base balance | Lifetime | 49 | GB 3 | 98.98 |
| Electrolyte and hormonal disorders | Lifetime | 88 | GB 6 | 98.81 |
| Body Composition Measurement Techniques | Lifetime | 81 | GB 7 | 99.00 |
| Neurological and metabolic disorders | Lifetime | 60 | GB 7 | 98.34 |
| Liver Disease and Transplantation | Lifetime | 374 | GB 33 | 98.98 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 51 | GB 3 | 98.44 |
| Nutrition and Health in Aging | Lifetime | 344 | GB 35 | 98.67 |
| Parathyroid Disorders and Treatments | Lifetime | 298 | GB 13 | 97.98 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 822 | GB 61 | 97.96 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 510 | GB 42 | 97.64 |
| Potassium and Related Disorders | Lifetime | 121 | GB 5 | 97.52 |
| Intramuscular injections and effects | Lifetime | 36 | GB 1 | 96.01 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 956 | GB 63 | 97.49 |
| Erythropoietin and Anemia Treatment | Lifetime | 217 | GB 11 | 96.46 |
| Chronic Kidney Disease and Diabetes | Lifetime | 683 | GB 31 | 96.38 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 763 | GB 82 | 95.06 |
| Neurological Complications and Syndromes | Lifetime | 300 | GB 9 | 95.09 |
| Frailty in Older Adults | Lifetime | 815 | GB 77 | 95.00 |
| Intracerebral and Subarachnoid Hemorrhage Research | Lifetime | 741 | GB 51 | 94.79 |
| Vasculitis and related conditions | Lifetime | 740 | GB 61 | 93.96 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 864 | GB 67 | 91.96 |
| Restless Legs Syndrome Research | Lifetime | 809 | GB 35 | 82.57 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 27 | GB 4 | 97.62 |
| Muscle and Compartmental Disorders | 2021-2025 | 7 | GB 3 | 97.48 |
| Dialysis and Renal Disease Management | 2021-2025 | 58 | GB 7 | 98.47 |
| Acute Kidney Injury Research | 2021-2025 | 63 | GB 5 | 96.67 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 100 | GB 6 | 96.14 |
| Nutrition and Health in Aging | 2021-2025 | 415 | GB 33 | 95.44 |
| Frailty in Older Adults | 2021-2025 | 444 | GB 44 | 92.97 |
| Body Composition Measurement Techniques | 2021-2025 | 286 | GB 12 | 88.20 |
| Parathyroid Disorders and Treatments | 2021-2025 | 550 | GB 33 | 85.88 |
| Neurological and metabolic disorders | 2021-2025 | 112 | GB 5 | 78.58 |
| Vitamin D Research Studies | 2021-2025 | 590 | GB 39 | 79.69 |
| Bone health and osteoporosis research | 2021-2025 | 703 | GB 38 | 81.74 |
| Renal function and acid-base balance | 2021-2025 | 304 | GB 11 | 71.73 |
| Electrolyte and hormonal disorders | 2021-2025 | 530 | GB 30 | 70.57 |
